We are live on ! Find out more
THRD

Third Harmonic Bio

Delisted

THRD was delisted on the 30th of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$142M
O
2
OrbiMed
New York
$75.1M
BI
3
BVF Inc
California
$56.8M
EC
4
EcoR1 Capital
California
$41.4M
GA
5
General Atlantic
New York
$38.5M
RCM
6
RA Capital Management
Massachusetts
$26.4M
BC
7
Boxer Capital
California
$26M
CC
8
Commodore Capital
New York
$20.1M +$3.65M +295,426 +24%
BlackRock
9
BlackRock
New York
$18.6M +$814K +65,778 +5%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$17.5M +$16.7M +1,349,234 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$11.4M +$277K +22,404 +3%
Citadel Advisors
12
Citadel Advisors
Florida
$8.85M +$8.42M +680,768 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$5.62M +$401K +32,409 +8%
State Street
14
State Street
Massachusetts
$5.02M +$67.9K +5,488 +1%
SSA
15
Schonfeld Strategic Advisors
New York
$4.29M +$1.49M +120,750 +58%
Invesco
16
Invesco
Georgia
$3.52M +$3.35M +270,989 New
SCM
17
Sio Capital Management
New York
$2.12M
Northern Trust
18
Northern Trust
Illinois
$1.98M -$44.7K -3,612 -2%
Charles Schwab
19
Charles Schwab
California
$1.79M +$84.8K +6,857 +5%
PHP
20
Parkman Healthcare Partners
Connecticut
$1.73M +$1.15M +93,325 +233%
Morgan Stanley
21
Morgan Stanley
New York
$1.66M -$30.3K -2,447 -2%
Renaissance Technologies
22
Renaissance Technologies
New York
$1.43M +$518K +41,900 +61%
Millennium Management
23
Millennium Management
New York
$1.33M -$1.9M -153,365 -60%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$1.18M +$82.9K +6,703 +8%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$801K +$91.2K +7,373 +14%